U.S. Markets open in 3 hrs 11 mins

Alimera Sciences (ALIM) Soars: Stock Zooms 62.8%

Zacks Equity Research

Alimera Sciences, Inc. (ALIM) was a big mover last session, as its shares rose nearly 63% on the day. This continues the recent uptrend for the company as the stock is now up almost 113% in the past one-month time frame.

 

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

 

Alimera currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

 

Some other medical stocks worth considering include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these companies carry a Zacks Rank #1 (Strong Buy).

 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ALIMERA SCIENCES INC (ALIM): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report

QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report


Zacks Investment Research